Comments
Novartis argues for Glivec patent at India's top court
12.09.2012. | NEW DELHI (Reuters) - Swiss drugmaker Novartis told India's top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the country's healthcare sector....
